Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care

Snyder, Margie E.; Earl, Tara R.; Gilchrist, Siobhan; Greenberg, Michael I.; Heisler, Holly; Revels, Michelle; Matson-Koffman, Dyann

doi:10.5888/pcd12.140504

Cited by 26 publications

(22 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other studies have focused on implementation barriers and facilitators of collaborative drug therapy management. 29,30 This study focused on physician satisfaction and experiences with the clinical pharmacists' role on primary care teams. A multidisciplinary model of care has the potential to improve the medication management for complex patients and increase physicians' ability to focus on patients' other clinical concerns.…”

Section: Discussionmentioning

confidence: 99%

Physician experiences with clinical pharmacists in primary care teams

Moreno¹,

Lonowski²,

Fu³

et al. 2017

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

a b s t r a c tBackground: Improving medication management is an important component of comprehensive care coordination for health systems. The Managing Your Medication for Education and Daily Support (MyMeds) medication management program at the University of California Los Angeles addresses medication management issues by embedding trained clinical pharmacists in primary care practice teams. Objectives: The aim of this work was to examine and explore physician opinions about the clinical pharmacist program and identify common themes among physician experiences as well as barriers to integration of clinical pharmacists into primary care practice teams. Methods: We conducted a mixed quantitativeequalitative methods study consisting of a crosssectional physician survey (n ¼ 69) as well as semistructured one-on-one physician interviews (n ¼ 13). Descriptive statistics were used to summarize survey responses, and standard qualitative content-analysis methods were used to identify major themes from the interviews. Results: The survey response rate was 61%; 13 interviews were conducted. Ninety percent of survey respondents agreed or strongly agreed that having the pharmacist in the office makes management of the patient's medication more efficient, 93% agreed or strongly agreed that pharmacist recommendations are clinically helpful, 71% agreed or strongly agreed that having access to a pharmacist has increased their knowledge about medications they prescribe, and 75% agreed or strongly agreed that having a pharmacist as part of the primary care team has made their job easier. Qualitative interviews corroborated survey findings, and physicians highlighted the value of the clinical pharmacist's communication, team care and expanded roles, and medication management. Conclusion: Primary care physicians valued the integrated pharmacy program highly, particularly its features of strong communication, expanded roles, and medication management. Pharmacists were viewed as integral members of the health care team.

show abstract

Section: Discussionmentioning

confidence: 99%

Physician experiences with clinical pharmacists in primary care teams

Moreno¹,

Lonowski²,

Fu³

et al. 2017

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

show abstract

“…There are significant overlapping themes found in both the CAPTION qualitative assessment and Snyder et al [16]. Key similarities include physician buy-in as a facilitator, and barriers such as lack of pharmacist reimbursement of services, trust of pharmacists to perform clinical functions, lack of pharmacist time and resources, and existing informal collaborations causing decreased interest in obtaining formal collaborative agreements.…”

Section: Discussionmentioning

confidence: 94%

“…There have been other studies that have evaluated the barriers to and physician perceptions of integrating pharmacists into team models [14,15] including a recently published case study by Snyder et al which examined 3 community-based sites utilizing provider-pharmacist collaborative drug therapy management [16]. To our knowledge none have evaluated barriers and facilitators in a large, randomized, multihealth system clinical trial.…”

Section: Introductionmentioning

confidence: 99%

Summative Evaluation of Physician-Pharmacist Collaboration Management

Finkelstein¹,

Blaine²

2016

J Hypertens (Los Angel)

View full text Add to dashboard Cite

show abstract

“…In this study we were able to explore common barriers for implementation of asthma‐specific tools into pharmacy workflow, which can serve as a useful resource for other similar interventions. Not surprisingly, the most common barriers were time and workflow, which are well‐established impediments to the provision of various pharmacy counselling services and asthma‐specific services . One of the possible solutions to this is engagement of the key stakeholders and development of optimal service delivery models, where greater efficiency of pharmacists’ clinical services can be supported by the pharmacy technicians.…”

Section: Discussionmentioning

confidence: 99%

“…Not surprisingly, the most common barriers were time and workflow, which are well-established impediments to the provision of various pharmacy counselling services and asthma-specific services. [23,[45][46][47][48][49][50] One of the possible solutions to this is engagement of the key stakeholders and development of optimal service delivery models, where greater efficiency of pharmacists' clinical services can be supported by the pharmacy technicians. For example, pharmacy technicians can be effective in identifying medication related problems, particularly nonadherence, when assisting with MTM services provision.…”

Section: Barriers and Facilitators To Implementation Of The Tools In mentioning

confidence: 99%

Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback

Makhinova

Barner

Brown

et al. 2018

J Pharm Health Serv Res

View full text Add to dashboard Cite

Objectives To develop tools for identifying and addressing medication adherence barriers so that they are asthma‐specific, to assess pharmacists’ perspectives on the use of the tools and their implementation in the community pharmacy practice. Methods Development of asthma adherence tools involved analysis of available tools that focused on identifying and resolving asthma‐specific barriers to adherence, followed by selection and modification of tools. Semi‐structured interviews were conducted with practicing community pharmacists on pharmacists’ experiences in addressing adherence for patients with asthma, barriers, special concerns and perceptions regarding the proposed tools and their implementation in practice. Audio‐recorded interviews were transcribed. Thematic analysis was conducted to describe pharmacists’ feedback. Key findings Three asthma‐specific tools, which were adapted from the Adherence Starts with Knowledge‐12 adherence tool and the Drug Adherence Work‐up tool, were utilized in this study, including: (1) a patient questionnaire to identify asthma medication adherence barriers, (2) a pharmacist ‘Conversation Starter’ document to efficiently facilitate identification and resolution of barrier(s), and (3) a patient pamphlet entitled ‘Breathe Easier’ to address and educate patients regarding identified barrier(s). Pharmacists’ (N = 5) overall perspectives on the approach and proposed tools were positive. All pharmacists acknowledged high patient need for asthma education and adherence support. Most of the interviewees agreed that common adherence barriers were addressed in the tools and that the main barrier regarding program implementation was time. Providing focused counselling by utilizing tools that identify specific patient issues and offer possible solutions may help overcome the time barrier. Conclusions The proposed tools can enhance patient–pharmacist communication and have the potential to improve adherence and overall asthma management, which can lead to a decreased asthma burden.

show abstract

Collaborative Drug Therapy Management: Case Studies of Three Community-Based Models of Care

Cited by 26 publications

References 14 publications

Physician experiences with clinical pharmacists in primary care teams

Physician experiences with clinical pharmacists in primary care teams

Summative Evaluation of Physician-Pharmacist Collaboration Management

Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback

Contact Info

Product

Resources

About